Kantum Pharma

Concord, United States

Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.

$3.5M raised

Jul 2021

Series A

Biopharma Biotechnology Health Care Therapeutics

Top Investors

Broadview Ventures Sidecar Angels 10X Venture Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kantum Pharma

How much funding has Kantum Pharma raised?

Kantum Pharma has raised $3.5M in total funding. The most recent round was Series A. The last funding was announced in July 2021.

Who are Kantum Pharma's investors?

Kantum Pharma's investors include Broadview Ventures, Sidecar Angels, 10X Venture Partners.

Where is Kantum Pharma headquartered?

Kantum Pharma is headquartered in Concord, United States.

What does Kantum Pharma do?

Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.

What stage is Kantum Pharma at?

Kantum Pharma is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 12, 2021.

MLA

"Kantum Pharma — Funding & Investors." VCBacked, July 12, 2021, https://www.vcbacked.co/company/kantum-pharma. Accessed July 2, 2026.

APA

VCBacked. (2021). Kantum Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kantum-pharma

Wikipedia (cite web)

{{cite web |title=Kantum Pharma — Funding & Investors |url=https://www.vcbacked.co/company/kantum-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 12, 2021.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.